Germany · 
Who invested in Sympatient?
Sympatient's investors include Verve Ventures.
Germany · Series A startup
Who invested in Sympatient
Funding summaryUpdated 26 Oct 2026
$7.4Mraised across 1 round since 2022, from 1 source
- Latest round
- Series A, $7.4MSept 2022
- Investors
- 1
The rounds
- Sept 2022
Founders and team
From Sympatient's own website: 3 founders, 9 on the team.
Jan-Niklas RöschCo-Founder & Chief Technology Officer
Benedikt ReinkeCo-Founder & Geschäftsführer Operations
Julian AngernCo-Founder & Geschäftsführer Produkt
- Ana JacobHead of Regulatory Affairs
- Chris HinzHead of Design
- Joachim PencHead of Backend & Software Architecture
- Kai OkamotoHead of Analytics
- Lena SchweikertHead of Regulatory Affairs
- Melissa KaczmarczykHead of People & Culture
- Kathrin PfeifferDirector Legal & Market Access
- Jonathan FriedrichTeam
- Marie TönniesTeam
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
This firm lists Sympatient as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.
Quick answers about Sympatient
How much has Sympatient raised?
Sympatient has raised $7.4M across 1 round since 2022.
When did Sympatient last raise?
Sympatient's most recent round was a Series A of $7.4M in Sept 2022.
What was Sympatient's biggest round?
Its most recent round, $7.4M in Sept 2022, is also its largest on record.
Who backed Sympatient first?
Sympatient's first round on record, in Sept 2022, was backed by Verve Ventures.
What stage is Sympatient at?
Sympatient's latest named round is a Series A, in Sept 2022.
Where is Sympatient based?
Sympatient is based in Germany.
Companies like Sympatient
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.